Therefore, we assessed enthesitis and bone erosion with ultrasonography and measured serum levels of IL-34 and RANKL using enzyme-linked immunosorbent assays (ELISA) to determine the correlations between serum levels of IL-34, RANKL, and enthesis lesions in patients with AS. This evidence concerns the gene IL34 and enthesitis.